Genrix (shanghai) Biopharmaceutical Co., Ltd.

This study tests an investigational drug called GR1802, given as an injection alongside standard allergy treatments, to see if it can better control symptoms like sneezing, runny nose, and itchy eyes in people with seasonal allergic rhinitis (hay fever). The trial will include 14…

This early-stage study tests a single dose of a new injection called GR2301 in 36 healthy adults in China. The main goal is to see if it is safe and how the body handles it. Participants are randomly assigned to get either the real drug or a placebo, and are followed for about 16…